Since the beginning of the year, the recently-launched Direxion Moonshot Innovators ETF has risen by over 24%, while the ARK Innovation ETF (another big player in the innovation investing space) has fallen by more than 8%. The difference between the two funds' performances is stark, and some investors believe it's a clear indicator that Moonshot is the superior ETF; however, that may not be the case. This Barron's article explains why the two funds are ill-suited for a proper head-to-head comparison — and why investors should be wary about buying into the Moonshot hype.